Skip to main content

Table 2 All-cause mortality and cardio-cerebrovascular events mortality (/1000 persons/year)

From: Effect of hyperlipidemia on the incidence of cardio-cerebrovascular events in patients with type 2 diabetes

Patients

Group

All-cause death

Mortality (95%CI)

Cardio-cerebrovascular events death

Mortality (95%CI)

Total

Diabetes

18

4.5 (3.67–5.98)

5

1.3 (0.98–1.65)

Diabetes combined with hyperlipidemia

32

8.4 (6.09–9.24)a

14

3.7 (2.97–4.02)a

< 65 years

Diabetes

9

2.2 (1.87–2.48)

3

0.6 (0.38–0.78)

Diabetes combined with hyperlipidemia

21

5.4 (4.81–5.94)a

8

1.7 (1.42–2.02)a

≥ 65 years

Diabetes

26

5.2 (4.89–5.42)

5

0.9 (0.88–1.02)

Diabetes combined with hyperlipidemia

23

5.4 (5.11–5.64)

6

1.1 (0.97–1.12)

Female

Diabetes

5

1.1 (0.87–1.28)

2

0.4 (0.28–0.53)

Diabetes combined with hyperlipidemia

17

4.4 (4.22–4.74)a

7

1.5 (1.42–1.62)a

Male

Diabetes

11

3.1 (2.87–3.28)

4

0.7 (0.64–0.83)

Diabetes combined with hyperlipidemia

25

4.9 (4.82–5.14)a

9

1.9 (1.83–2.02)a

Family history

Diabetes

10

2.8 (2.57–2.98)

6

0.6 (0.58–0.73)

 

Diabetes combined with hyperlipidemia

25

5.9 (5.53–6.14)a

12

1.9 (1.83–2.02)a

No family history

Diabetes

17

3.6 (3.37–3.88)

10

1.6 (1.48–1.73)

 

Diabetes combined with hyperlipidemia

20

3.9 (3.53–4.14)

12

1.9 (1.83–2.02)

  1. CI confidence interval
  2. Note: aP < 0.05, which is compared with the same patients in diabetes group